Analysis | Samples | Factors | Units |
---|---|---|---|
Reversed phase POSITIVE ION MODE | ASPC-CATP-1 | Treatment:25µl DMSO and 40µM ATP for 72h | counts |
Reversed phase POSITIVE ION MODE | ASPC-CATP-2 | Treatment:25µl DMSO and 40µM ATP for 72h | counts |
Reversed phase POSITIVE ION MODE | ASPC-CATP-3 | Treatment:25µl DMSO and 40µM ATP for 72h | counts |
Reversed phase POSITIVE ION MODE | ASPC-CATP-4 | Treatment:25µl DMSO and 40µM ATP for 72h | counts |
Reversed phase POSITIVE ION MODE | ASPC-CATP-5 | Treatment:25µl DMSO and 40µM ATP for 72h | counts |
Reversed phase POSITIVE ION MODE | ASPC-GATP-1-r002 | Treatment:50µM gemcitabine and 40µM ATP for 72h | counts |
Reversed phase POSITIVE ION MODE | ASPC-GATP-2 | Treatment:50µM gemcitabine and 40µM ATP for 72h | counts |
Reversed phase POSITIVE ION MODE | ASPC-GATP-3 | Treatment:50µM gemcitabine and 40µM ATP for 72h | counts |
Reversed phase POSITIVE ION MODE | ASPC-GATP-4 | Treatment:50µM gemcitabine and 40µM ATP for 72h | counts |
Reversed phase POSITIVE ION MODE | ASPC-GATP-5 | Treatment:50µM gemcitabine and 40µM ATP for 72h | counts |
Reversed phase NEGATIVE ION MODE | ASPC-CATP-1 | Treatment:25µl DMSO and 40µM ATP for 72h | counts |
Reversed phase NEGATIVE ION MODE | ASPC-CATP-2 | Treatment:25µl DMSO and 40µM ATP for 72h | counts |
Reversed phase NEGATIVE ION MODE | ASPC-CATP-3 | Treatment:25µl DMSO and 40µM ATP for 72h | counts |
Reversed phase NEGATIVE ION MODE | ASPC-CATP-4 | Treatment:25µl DMSO and 40µM ATP for 72h | counts |
Reversed phase NEGATIVE ION MODE | ASPC-CATP-5 | Treatment:25µl DMSO and 40µM ATP for 72h | counts |
Reversed phase NEGATIVE ION MODE | ASPC-GATP-1-r002 | Treatment:50µM gemcitabine and 40µM ATP for 72h | counts |
Reversed phase NEGATIVE ION MODE | ASPC-GATP-2 | Treatment:50µM gemcitabine and 40µM ATP for 72h | counts |
Reversed phase NEGATIVE ION MODE | ASPC-GATP-3 | Treatment:50µM gemcitabine and 40µM ATP for 72h | counts |
Reversed phase NEGATIVE ION MODE | ASPC-GATP-4 | Treatment:50µM gemcitabine and 40µM ATP for 72h | counts |
Reversed phase NEGATIVE ION MODE | ASPC-GATP-5 | Treatment:50µM gemcitabine and 40µM ATP for 72h | counts |